Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals-Reference-Cited by-同舟云学术

Access to palivizumab among children at high risk of respiratory syncytial virus complications in English hospitals

Published:2021-10-07 Issue: Volume: Page:
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Zylbersztejn Ania¹^ORCID,Almossawi Ofran¹,Gudka Nikesh²,Tompsett Daniel¹,De Stavola Bianca¹,Standing Joseph F.³^ORCID,Smyth Rosalind³,Hardelid Pia¹

Affiliation:

1. Population, Policy & Practice Research and Teaching Department UCL Great Ormond Street Institute of Child Health London UK

2. Great Ormond Street Hospital London UK

3. Infection, Immunity and Inflammation Research and Teaching Department UCL Great Ormond Street Institute of Child Health London UK

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.15069

Reference41 articles.

1. Global and National Burden of Diseases and Injuries Among Children and Adolescents Between 1990 and 2013

2. NHS Digital.Hospital Admitted Patient Care Activity 2017–18.https://digital.nhs.uk/data-and-information/publications/statistical/hospital-admitted-patient-care-activity/2017-18. Published2018. Accessed February 12 2019.

3. Risk Factors for Hospital Admission with RSV Bronchiolitis in England: A Population-Based Birth Cohort Study

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Policy Decisions and Their Implications Regarding Preventive Interventions for Respiratory Syncytial Virus (RSV) Infection in Canadian Infants: A Primer for Nurses;Neonatal Network;2023-08-01

2. Respiratory Syncytial Virus: A Systematic Review and Meta-Analysis of Tomographic Findings (2000–2022);Children;2023-07-05

3. Respiratory Syncytial Virus Prevention through Monoclonal Antibodies: A Cross-Sectional Study on Knowledge, Attitudes, and Practices of Italian Pediatricians;Pediatric Reports;2023-02-20

4. Target Trial Emulation and Bias Through Missing Eligibility Data: An Application to a Study of Palivizumab for the Prevention of Hospitalization Due to Infant Respiratory Illness;American Journal of Epidemiology;2022-12-12

5. RSV disease in infants and young children: Can we see a brighter future?;Human Vaccines & Immunotherapeutics;2022-06-20